共 873 条
[91]
Steiner T(2010)Bedside use of a dual aortic balloon occlusion for the treatment of cerebral vasospasm Neurocrit Care 13 385-8
[92]
Al-Shahi Salman R(2009)Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm South Med J 102 150-3
[93]
Beer R(1999)Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans Stroke 30 1409-16
[94]
Christensen H(2010)Intra-aortic balloon pump counterpulsation in the setting of subarachnoid hemorrhage, cerebral vasospasm, and neurogenic stress cardiomyopathy. Case report and review of the literature Neurocrit Care 13 101-8
[95]
Cordonnier C(2010)Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group Stroke 41 2391-5
[96]
Csiba L(1993)A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study J Neurosurg 78 537-47
[97]
Forsting M(2006)Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH Study Stroke. 37 2326-30
[98]
Harnof S(2003)No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial J Neurosurg. 99 953-9
[99]
Klijn CJM(2009)Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article J Neurosurg. 111 171-80
[100]
Krieger D(2012)Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial Lancet 380 44-9